The regulatory T cells in anti-influenza antibody response post influenza vaccination

References

• Wright PF, Neuman G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Ramb RA, Roizman B, et al, editors. Fields virology 5th ed. Philadelphia Lippincott-Raven; 2007, 1691-740.
   Google Scholar
• McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186:341 - 50; http://dx.doi.org/10.1086/341462; PMID: 12134230
   PubMed Web of Science ®Google Scholar
• de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352:686 - 91; http://dx.doi.org/10.1056/NEJMoa044307; PMID: 15716562
   PubMed Web of Science ®Google Scholar
• Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med 2009; 361:115 - 9; http://dx.doi.org/10.1056/NEJMp0904572; PMID: 19474418
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006; 194:1032 - 9; http://dx.doi.org/10.1086/507309; PMID: 16991077
   PubMed Web of Science ®Google Scholar
• Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008; 26:Suppl 4 D31 - 4; http://dx.doi.org/10.1016/j.vaccine.2008.07.078; PMID: 19230156
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513 - 22; http://dx.doi.org/10.1056/NEJMoa061850; PMID: 17167134
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531 - 62; http://dx.doi.org/10.1146/annurev.immunol.21.120601.141122; PMID: 15032588
   PubMed Web of Science ®Google Scholar
• Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002; 3:756 - 63; PMID: 12089509
   PubMed Web of Science ®Google Scholar
• Ziegler SE, Morella KK, Anderson D, Kumaki N, Leonard WJ, Cosman D, et al. Reconstitution of a functional interleukin (IL)-7 receptor demonstrates that the IL-2 receptor gamma chain is required for IL-7 signal transduction. Eur J Immunol 1995; 25:399 - 404; http://dx.doi.org/10.1002/eji.1830250214; PMID: 7875201
   PubMed Web of Science ®Google Scholar
• Chabalgoity JA, Baz A, Rial A, Grille S. The relevance of cytokines for development of protective immunity and rational design of vaccines. Cytokine Growth Factor Rev 2007; 18:195 - 207; http://dx.doi.org/10.1016/j.cytogfr.2007.01.016; PMID: 17347024
   PubMed Web of Science ®Google Scholar
• Yucesoy B, Johnson VJ, Fluharty K, Kashon ML, Slaven JE, Wilson NW, et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine 2009; 27:6991 - 7; http://dx.doi.org/10.1016/j.vaccine.2009.09.076; PMID: 19819209
   PubMed Web of Science ®Google Scholar
• Wan YY, Flavell RA. ‘Yin-Yang’ functions of transforming growth factor-β and T regulatory cells in immune regulation. Immunol Rev 2007; 220:199 - 213; http://dx.doi.org/10.1111/j.1600-065X.2007.00565.x; PMID: 17979848
   PubMed Web of Science ®Google Scholar
• Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003; 198:1875 - 86; http://dx.doi.org/10.1084/jem.20030152; PMID: 14676299
   PubMed Web of Science ®Google Scholar
• Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24:677 - 88; http://dx.doi.org/10.1016/j.immuni.2006.06.002; PMID: 16782025
   PubMed Web of Science ®Google Scholar
• Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979; 35:69 - 75; PMID: 367490
   PubMed Web of Science ®Google Scholar
• Hirota Y, Kaji M, Ide S, Kajiwara J, Kataoka K, Goto S, et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. Vaccine 1997; 15:962 - 7; http://dx.doi.org/10.1016/S0264-410X(96)00302-7; PMID: 9261942
   PubMed Web of Science ®Google Scholar
• Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al, Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:RR-8 1 - 62; PMID: 20689501
   PubMedGoogle Scholar
• van’t Land B, Schijf M, van Esch BCAM, van Bergenhenegouwen J, Bastiaans J, Schouten B, et al. Regulatory T-cells have a prominent role in the immune modulated vaccine response by specific oligosaccharides. Vaccine 2010; 28:5711 - 7; http://dx.doi.org/10.1016/j.vaccine.2010.06.046; PMID: 20600499
   PubMed Web of Science ®Google Scholar
• Cone RE, Bhowmick S. Cytokines and sympathy: the control of regulatory T cells. Int J Interferon Cytokine Mediator Res 2010; 2:41 - 7; http://dx.doi.org/10.2147/IJICMR.S6758
   Google Scholar
• Surls J, Nazarov-Stoica C, Kehl M, Casares S, Brumeanu T-D. Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination. Vaccine 2010; 28:7319 - 30; http://dx.doi.org/10.1016/j.vaccine.2010.08.074; PMID: 20832492
   PubMed Web of Science ®Google Scholar
• Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci USA 2005; 102:4091 - 6; http://dx.doi.org/10.1073/pnas.0408679102; PMID: 15753306
   PubMed Web of Science ®Google Scholar
• Wang J, Ioan-Facsinay A, van der Voort EIH, Huizinga TWJ, Toes REM. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007; 37:129 - 38; http://dx.doi.org/10.1002/eji.200636435; PMID: 17154262
   PubMed Web of Science ®Google Scholar
• Sharma MD, Hou DY, Baban B, Koni PA, He Y, Chandler PR, et al. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. Immunity 2010; 33:942 - 54; http://dx.doi.org/10.1016/j.immuni.2010.11.022; PMID: 21145762
   PubMed Web of Science ®Google Scholar
• Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, Bloquet S, et al. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Eur J Immunol 2010; 40:2528 - 38; http://dx.doi.org/10.1002/eji.201040531; PMID: 20690182
   PubMed Web of Science ®Google Scholar
• Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191 - 8; http://dx.doi.org/10.1038/ni1009; PMID: 14625547
   PubMed Web of Science ®Google Scholar
• Huang J, Ma R, Wu CY. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine 2006; 24:4905 - 13; http://dx.doi.org/10.1016/j.vaccine.2006.03.058; PMID: 16621188
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176:6333 - 9; PMID: 16670345
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Upshaw CM, Hooton JW, Lechelt KE, Meneilly GS. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 1998; 16:1742 - 7; http://dx.doi.org/10.1016/S0264-410X(98)00133-9; PMID: 9778750
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Hooton JW, Hooton N, Bleackley RC. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 2005; 23:3294 - 300; http://dx.doi.org/10.1016/j.vaccine.2005.01.080; PMID: 15837235
   PubMed Web of Science ®Google Scholar
• Sette AM, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, Johnston RJ, et al. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 2008; 28:847 - 58; http://dx.doi.org/10.1016/j.immuni.2008.04.018; PMID: 18549802
   PubMed Web of Science ®Google Scholar
• Casares N, Rudilla F, Arribillaga L, Llopiz D, Riezu-Boj JI, Lozano T, et al. A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice. J Immunol 2010; 185:5150 - 9; http://dx.doi.org/10.4049/jimmunol.1001114; PMID: 20870946
   PubMed Web of Science ®Google Scholar
• Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693 - 700; http://dx.doi.org/10.1084/jem.20060468; PMID: 16818676
   PubMed Web of Science ®Google Scholar
• Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006; 103:6659 - 64; http://dx.doi.org/10.1073/pnas.0509484103; PMID: 16617117
   PubMed Web of Science ®Google Scholar